AAAAAA

   
Results: 1-18 |
Results: 18
LONG-TERM ADMINISTRATION OF G-CSF DOES NOT INCREASE AT 5 YEARS THE RISK OF CYTOGENETIC ABNORMALITIES IN PATIENTS WITH SEVERE APLASTIC-ANEMIA
Authors: BACIGALUPO A BROCCIA G CORDA G ARCESE W DIBONA E CAROTENUTO M GALLAMINI A LOCATELLI F MORI P SARACCO P TODESCHINI G COSER P IACOPINO P VANLINT MT
Citation: A. Bacigalupo et al., LONG-TERM ADMINISTRATION OF G-CSF DOES NOT INCREASE AT 5 YEARS THE RISK OF CYTOGENETIC ABNORMALITIES IN PATIENTS WITH SEVERE APLASTIC-ANEMIA, Experimental hematology, 26(8), 1998, pp. 235-235
LATE INTENSIFICATION THERAPY WITH OR WITHOUT PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANT (PBPCT) IN BREAST-CANCER LARGER THAN 3 CM AND WITH10 OR MORE POSITIVE NODES
Authors: MASSIDDA B IONTA MT CASULA P BROCCIA G
Citation: B. Massidda et al., LATE INTENSIFICATION THERAPY WITH OR WITHOUT PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANT (PBPCT) IN BREAST-CANCER LARGER THAN 3 CM AND WITH10 OR MORE POSITIVE NODES, Breast, 6(5), 1997, pp. 902-902
MODIFICATION OF LIPID-METABOLISM AND EXPRESSION OF RELATED GENES IN HEMATOLOGIC NEOPLASMS
Authors: BATETTA B PIRAS S PUTZOLU M BONATESTA RR PULISCI D BROCCIA G SPANO O SANNA F DESSI S PANI P
Citation: B. Batetta et al., MODIFICATION OF LIPID-METABOLISM AND EXPRESSION OF RELATED GENES IN HEMATOLOGIC NEOPLASMS, Atherosclerosis, 133(2), 1997, pp. 8-8
MOLECULAR REMISSION IN PML RAR-ALPHA-POSITIVE ACUTE PROMYELOCYTIC LEUKEMIA BY COMBINED ALL-TRANS-RETINOIC ACID AND IDARUBICIN (AIDA) THERAPY/
Authors: MANDELLI F DIVERIO D AVVISATI G LUCIANO A BARBUI T BERNASCONI C BROCCIA G CERRI R FALDA M FIORITONI G LEONI F LISO V PETTI MC RODEGHIERO F SAGLIO G VEGNA ML VISANI G JEHN U WILLEMZE R MUUS P PELICCI PG BIONDI A LOCOCO F
Citation: F. Mandelli et al., MOLECULAR REMISSION IN PML RAR-ALPHA-POSITIVE ACUTE PROMYELOCYTIC LEUKEMIA BY COMBINED ALL-TRANS-RETINOIC ACID AND IDARUBICIN (AIDA) THERAPY/, Blood, 90(3), 1997, pp. 1014-1021
OUTCOME OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA WHO FAILED TO RESPONDTO A SINGLE COURSE OF FIRST-LINE INDUCTION THERAPY - A GIMEMA STUDY OF 218 UNSELECTED CONSECUTIVE PATIENTS
Authors: LISO V IACOPINO P AVVISATI G PETTI MC BROCCIA G CAROTENUTO M FALDA M FAZI P LAZZARINO M LEONI P MIRTO S PUCCI G NOBILE F NOSARI AM SPECCHIA G STASI R TABILIO A MANDELLI F
Citation: V. Liso et al., OUTCOME OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA WHO FAILED TO RESPONDTO A SINGLE COURSE OF FIRST-LINE INDUCTION THERAPY - A GIMEMA STUDY OF 218 UNSELECTED CONSECUTIVE PATIENTS, Leukemia, 10(9), 1996, pp. 1443-1452
PROGNOSTIC FACTORS OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML) ALLOGRAFTED IN FIRST COMPLETE REMISSION - AN ANALYSIS OF THE EORTC-GIMEMA AML 8A TRIAL
Authors: KEATING S SUCIU S DEWITTE T MANDELLI F WILLEMZE R RESEGOTTI L BROCCIA G THALER J LABAR B DAMASIO E BIZZI B ROTOLI B VEKHOFF A MUUS P PETTI MC DARDENNE M SOLBU G VEGNA ML ZITTOUN R
Citation: S. Keating et al., PROGNOSTIC FACTORS OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML) ALLOGRAFTED IN FIRST COMPLETE REMISSION - AN ANALYSIS OF THE EORTC-GIMEMA AML 8A TRIAL, Bone marrow transplantation, 17(6), 1996, pp. 993-1001
CHRONIC MYELOID-LEUKEMIA, BCR ABL TRANSCRIPT, RESPONSE TO ALPHA-INTERFERON AND SURVIVAL/
Authors: BACCARANI M TURA S RUSSO D BACCARANI M ZACCARIA A SAGLIO G GUERRASIO A MARTINELLI G ZUFFA E TESTONI N FARABEGOLI P ZAMAGNI MD FANIN R DAMIANI D DEMILIO A BATTISTA R SPECCHIA G LISO V DITUCCI A BROCCIA G MONTEFUSCO E MANDELLI F RAMBALDI A BARBUI T BODENIZZA CA CAROTENUTO M ROTONDO SG AMBROSETTI A PERONA G LUCIANO L ROTOLI B RONCO F NOBILE F TABILIO A LIBERATI A MARTELLI M GRIGNANI F PARDINI S LONGINOTTI M GENTILINI I COSER P LEONI F CIOLLI S MORRA E BERNASCONI C FERRERO D PILERI A LEONI P DANIELI G ABBADESSA A BRUZZESE L TRINGALI S CARONIA F GALIENI P DISPENSA E NOVARINO A CAPUCCI A IZZI T NOSARI A PIZZUTI M RICCIUTI F VASINO AC RESEGOTTI L CAPALDI A GIOVANNELLI E
Citation: M. Baccarani et al., CHRONIC MYELOID-LEUKEMIA, BCR ABL TRANSCRIPT, RESPONSE TO ALPHA-INTERFERON AND SURVIVAL/, Leukemia, 9(10), 1995, pp. 1648-1652
ANTILYMPHOCYTE GLOBULIN, CYCLOSPORINE, AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH ACQUIRED SEVERE APLASTIC-ANEMIA (SAA) - APILOT-STUDY OF THE EBMT SAA WORKING PARTY
Authors: BACIGALUPO A BROCCIA G CORDA G ARCESE W CAROTENUTO M GALLAMINI A LOCATELLI F MORI PG SARACCO P TODESCHINI G COSER P IACOPINO P VANLINT MT GLUCKMAN E
Citation: A. Bacigalupo et al., ANTILYMPHOCYTE GLOBULIN, CYCLOSPORINE, AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH ACQUIRED SEVERE APLASTIC-ANEMIA (SAA) - APILOT-STUDY OF THE EBMT SAA WORKING PARTY, Blood, 85(5), 1995, pp. 1348-1353
LONG-TERM CONTINUOUS COMPLETE REMISSION OF ACUTE MYELOID-LEUKEMIA IN A JEHOVAH-WITNESS TREATED WITHOUT BLOOD SUPPORT
Authors: BROCCIA G
Citation: G. Broccia, LONG-TERM CONTINUOUS COMPLETE REMISSION OF ACUTE MYELOID-LEUKEMIA IN A JEHOVAH-WITNESS TREATED WITHOUT BLOOD SUPPORT, Haematologica, 79(2), 1994, pp. 180-181
EFFECTS OF TEICOPLANIN AND THOSE OF VANCOMYCIN IN INITIAL EMPIRICAL ANTIBIOTIC REGIMEN FOR FEBRILE - NEUTROPENIC PATIENTS WITH HEMATOLOGIC MALIGNANCIES
Authors: MENICHETTI F MARTINO P BUCANEVE G GENTILE G DANTONIO D LISO V RICCI P NOSARI AM BUELLI M CAROTENUTO M FASOLA G JACOPINO P MONTILLO M BARBABIETOLA G GIRMENIA C DELFAVERO A ISABELLA N DINOTA A FONTANA R PAGANO L BROCCIA G CUDILLO L GALIENI P DIFAZIO S CARELLA AM QUINTINI G LANDONIO G CHIERICHINI A PACILLI L FERRANDINA C DALLASTA A GABBAS A CITARELLA P DORE F
Citation: F. Menichetti et al., EFFECTS OF TEICOPLANIN AND THOSE OF VANCOMYCIN IN INITIAL EMPIRICAL ANTIBIOTIC REGIMEN FOR FEBRILE - NEUTROPENIC PATIENTS WITH HEMATOLOGIC MALIGNANCIES, Antimicrobial agents and chemotherapy, 38(9), 1994, pp. 2041-2046
INTERFERON ALFA-2A AS COMPARED WITH CONVENTIONAL CHEMOTHERAPY FOR THETREATMENT OF CHRONIC MYELOID LEUKEMIA
Authors: TURA S BACCARANI M ZUFFA E RUSSO D ZACCARIA A FIACCHINI M TESTONI N ZAMAGNI MD MARTINELLI G DAMIANI D MICHIELI M FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C ALIMENA G MANDELLI F LEONI P DANIELI G NOSARI A DECATALDO F MAJOLINO I CARONIA F LIBERATI AM GRIGNANI F TABILIO A MARTELLI M PAOLINO F RESEGOTTI L DITUCCI A BROCCIA G LEONI F CIOLLI S LUCIANO L ROTOLI B PERRICONE R CAJOZZO A MONTUORO A DELAURENZI A VOLPE E DEMILIO A BATTISTA R CAPUCCI A IZZI T SCAPOLI GL CASTOLDI GL LOMBARDO M TORLONTANO G LANDOLFI R LEONE G DELFINI C SPARAVENTI G PAPINESCHI F SPREMOLLA G RISSO M MARMONT AM DINI D DIPRISCO U MANGONI L RIZZOLI V GIRINO M ASCARI E BODENIZZA CA CAROTENUTO M DIFRANCESCO A QUAGLINO D NARDELLI S CICCONE F MIRAGLIA E DEBIASE R GALLO E PILERI A RAMBALDI A BARBUI T MORANDI S BIANCHINI E DEROSA C CIMINO R RONCA F NOBILE F CANTONETTI M PAPA G GALLAMINI A BUFFA F MUSOLINO C SQUADRITO G CAPALDI A GIOVANNELLI E PINOTTI G VENCO A ZAGONEL V PINTO A GENTILINI I COSER P GUGLIELMO P CACCIOLA E PIZZUTI M RICCIUTI F FANIN R CRISCUOLO D MONTEFUSCO E
Citation: S. Tura et al., INTERFERON ALFA-2A AS COMPARED WITH CONVENTIONAL CHEMOTHERAPY FOR THETREATMENT OF CHRONIC MYELOID LEUKEMIA, The New England journal of medicine, 330(12), 1994, pp. 820-825
LONG-TERM SURVIVORS IN CHRONIC GRANULOCYTIC-LEUKEMIA - A STUDY BY THEINTERNATIONAL CGL PROGNOSIS STUDY-GROUP
Authors: CERVANTES F ROBERTSON JE ROZMAN C BACCARANI M TURA S GOMEZ GA BRAUN TJ CLARKSON BD PEREIRA A ZACCARIA A ZUFFA E MANDELLI F ALIMENA G MONTEFUSCO E RUSSO D FANIN R GRIGNANI F MARTELLI MF MORRA E BERNASCONI C CAJOZZO A PERONA G AMBROSETTI A LEONI P LOMBARDO M DELFINI C TORLONTANO G PORCELLINI A DEMILIO A BATTISTA R LEONI F GUGLIELMO P GIUSTOLISI R DECATALDO F NOSARI A RIZZOLI V MANGONI M CARNEVALI C LISO V SPECCHIA G BAJETTA E BROCCIA G DITUCCI A BUSINCO A BRUZZESE L ABADESA A LANZI E ALBERTI A NERI A RONCO F TONATO M GRIFONI V
Citation: F. Cervantes et al., LONG-TERM SURVIVORS IN CHRONIC GRANULOCYTIC-LEUKEMIA - A STUDY BY THEINTERNATIONAL CGL PROGNOSIS STUDY-GROUP, British Journal of Haematology, 87(2), 1994, pp. 293-300
PREVENTING FUNGAL INFECTION IN NEUTROPENIC PATIENTS WITH ACUTE-LEUKEMIA - FLUCONAZOLE COMPARED WITH ORAL AMPHOTERICIN-B
Authors: MENICHETTI F DELFAVERO A MARTINO P BUCANEVE G MICOZZI A DANTONIO D RICCI P CAROTENUTO M LISO V NOSARI AM BARBUI T FASOLA G MANDELLI F MONTILLO M BARBABIETOLA G DINOTA A PAGANO L JACOPINO P ISABELLA N FONTANA R LANDONIO G BROCCIA G CUDILLO L DIFAZIO S PACILLI L MONACO M CARELLA AM CHIERICHINI A QUINTINI G GABBAS A CITARELLA P DALLASTA A RONCONI F DORE F GALIENI P
Citation: F. Menichetti et al., PREVENTING FUNGAL INFECTION IN NEUTROPENIC PATIENTS WITH ACUTE-LEUKEMIA - FLUCONAZOLE COMPARED WITH ORAL AMPHOTERICIN-B, Annals of internal medicine, 120(11), 1994, pp. 913-918
PROGNOSTIC FACTORS IN CHRONIC MYELOID-LEUKEMIA - RELATIONSHIP WITH INTERFERON AND BONE-MARROW TRANSPLANTATION
Authors: TURA S RUSSO D FANIN R ZUFFA E PATRIARCA F FIACCHINI M BACCARANI M TESTONI N ZAMAGNI MD ZACCARIA A MONTEFUSCO E ALIMENA G MELONI G MANDELLI F DAMIANI D MICHIELI M SILVESTRI F VIRGOLINI L CRISCUOLO D FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C DEMILIO A BATTISTA R DITUCCI A BROCCIA G MAJOLINO I CARONIA F LUCIANO L ROTOLI B LEONI P BODENIZZA CA CAROTENUTO M ROTONDO SG NOSARI A DECATALDO F MONTUORO A DELAURENZI A LIBERATI AM TABILIO A MARTELLI M RAMBALDI A BARBUI T LEONI F CIOLLI S RONCA F NOBILE F PAOLINO F RESEGOTTI L PAPINESCHI F SPREMOLLA G LANDOLFI R LEONE G VOLPE E MANGONI L RIZZOLI V CAPUCCI A IZZI T GENTILINI I COSER P GALLO E PILERI A CANTONETTI M PAPA G DINI D DIPRISCO U MORANDI S BIANCHINI E PINOTTI G VENCO A ZAGONEL V PINTO A CAPALDI A GIOVANNELLI E PIZZUTI M RICCIUTI F AMBROSETTI A PERONA G PERRICONE R CAJOZZO A LOMBARDO M TORLONTANO G DELFINI C LUCARELLI G GIRINO M ASCARI E
Citation: S. Tura et al., PROGNOSTIC FACTORS IN CHRONIC MYELOID-LEUKEMIA - RELATIONSHIP WITH INTERFERON AND BONE-MARROW TRANSPLANTATION, Leukemia & lymphoma, 11, 1993, pp. 67-71
WILL MOLECULAR-BIOLOGY CONTRIBUTE TO REFINE PROGNOSIS AND TO SELECT TREATMENT
Authors: ZACCARIA A MARTINELLI G BUZZI M FARABEGOLI P SAGLIO G GUERRASIO A BERNABEI PA SANTINI V PELLICCI PG MENCARELLI A COCO FL DIVERIO D RAMBALDI A SANTORO A TURA S RUSSO D ZUFFA E FANIN R PATRIARCA F FIACCHINI M BACCARANI M TESTONI N ZAMAGNI MD ZACCARIA A MONTEFUSCO E ALIMENA G MELONI G MANDELLI F DAMIANI D MICHIELI M CRISCUOLO D FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C DEMILIO A BATTISTA R DITUCCI A BROCCIA G MAIOLINO I CARONIA F LUCIANO L ROTOLI B LEONI P DANIELI G BODENIZZA CA CAROTENUTO M ROTONDO SG NOSARI A DECATALDO F MONTUORO A DELAURENZI A CAMILLO S LIBERATI AM GRIGNANI F TABILIO A MARTELLI M RAMBALDI A BARBUI T LEONI F CIOLLI S RONCA F NOBILE F PAOLINO F RESEGOTTI L PAPINESCHI F SPREMOLLA G LANDOLFI R LEONE G VOLPE E MANGONI L RIZZOLI V CAPUCCI A IZZI T SCAPOLI GL CASTOLDI GL GENTILINI I COSER P GALLO E PILERI A CANTONETTI M PAPA G DINI D MORANDI S BIANCHINI E PINOTTI G VENCO A ZAGONEL V PINTO A CAPALDI A GIOVANNELLI E PIZZUTI M RICCIUTI F AMBROSETTI A CAJOZZO A LOMBARDO M TORLONTANO G DELFINI C LUCARELLI G GIRINO M ASCARI E RISSO M DAMASIO E MARTINO S PARDINI S LONGINOTTI M MIRAGLIA E DEBIASE R NARDELLI S GALIENI P DISPENSA E ABBADESSA A BRUZZESE L PROSSOMARITI L CIMINO R DEROSA C GABBAS A FRANCESCO S GALLAMINI A DIFRANCESCO A QUAGLINO D MUSOLINO C SQUADRITO G AVANZINI P GOBBI F NUOVA ASM EMILIA R SAGLIO G AGLIETTA M CAMASCHELLA C MAZZA MU GUGLIELMO P CACCIOLA E MONACO M
Citation: A. Zaccaria et al., WILL MOLECULAR-BIOLOGY CONTRIBUTE TO REFINE PROGNOSIS AND TO SELECT TREATMENT, Leukemia & lymphoma, 11, 1993, pp. 81-89
TREATMENT OF PH-POSITIVE CHRONIC MYELOID-LEUKEMIA WITH ALPHA-INTERFERON (ROFERON-A) - THE ITALIAN COOPERATIVE STUDY-GROUP EXPERIENCE
Authors: TURA S RUSSO D ZUFFA E FANIN R PATRIARCA F FIACCHINI M BACCARANI M TESTONI N ZAMAGNI MD ZACCARIA A MONTEFUSCO E ALIMENA G MELONI G MANDELLI F DAMIANI D MICHIELI M CRISCUOLO D FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C DEMILIO A BATTISTA R DITUCCI A BROCCIA G MAIOLINO I CARONIA F LUCIANO L ROTOLI B LEONI P DANIELI G BODENIZZA CA CAROTENUTO M ROTONDO SG NOSARI A DECATALDO F MONTUORO A DELAURENZI A CAMILLO S LIBERATI AM GRIGNANI F TABILIO A RAMBALDI A BARBUI T LEONI F CIOLLI S RONCA F NOBILE F PAOLINO F RESEGOTTI L PAPINESCHI F SPREMOLLA G LANDOLFI R LEONE G VOLPE E MANGONI L RIZZOLI V CAPUCCI A IZZI T SCAPOLI GL CASTOLDI GL GENTILINI I COSER P GALLO E PILERI A CANTONETTI M PAPA G DINI D DIPRISCO U MORANDI S BIANCHINI E PINOTTI G VENCO A ZAGONEL V PINTO A CAPALDI A GIOVANNELLI E PIZZUTI M RICCIUTI F AMBROSETTI A PERONA G PERRICONE R CAJOZZO A LOMBARDO M TORLONTANO G DELFINI C LUCARELLI G GIRINO M ASCARI E RISSO M DAMASIO E MARTINO S PARDINI S LONGINOTTI M MIRAGLIA E DEBIASE R NARDELLI S CICCONE F GALIENI P DISPENSA E ABBADESSA A BRUZZESE L PROSSOMARITI L CIMINO R DEROSA C GABBAS A FRANCESCO S GALLAMINI A DIFRANCESCO A QUAGLINO D MUSOLINO C SQUADRITO G AVANZINI P GOBBI F NUOVA ASM EMILIA R SAGLIO G AGLIETTA M CAMASCHELLA C MAZZA MU GUGLIELMO P CACCIOLA E MONACO M
Citation: S. Tura et al., TREATMENT OF PH-POSITIVE CHRONIC MYELOID-LEUKEMIA WITH ALPHA-INTERFERON (ROFERON-A) - THE ITALIAN COOPERATIVE STUDY-GROUP EXPERIENCE, Leukemia & lymphoma, 11, 1993, pp. 153-157
KARYOTYPIC CONVERSION BY INTERFERON AS PREPARATIVE TREATMENT FOR AUTOLOGOUS BMT IN PH POSITIVE CML
Authors: GOBBI M TURA S RUSSO D ZUFFA E PATRIARCA F FIACCHINI M GOBBI M BACCARANI M MONTEFUSCO E MELONI G MANDELLI F ZAMAGNI MD TESTONI N ZACCARIA A FANIN R DAMIANI D MICHIELI M CRISCUOLO D FOWST C HOLDENER EE SPECCHIA G LISO V DEMILIO A BATTISTA R DITUCCI A BROCCIA G BODENIZZA CA CAROTENUTO M ROTONDO G AMBROSETTI A PERONA G MAJOLINO I CARONIA F LUCIANO L ROTOLI B MORRA E BERNASCONI C RAMBALDI A BARBUI T RONCO F NOBILE F LEONI P NOSARI A DECATALDO F MONTUORO A DELAURENZI A CAMILLO S GENTILINI I COSER P DINI D DIPRISCO U PAPINESCHI F SPREMOLLA G LIBERATI A GRIGNANI G TABILIO A MARTELLI M PARDINI S LONGINOTTI M MANGONI L RIZZOLI V GALIENI P DISPENSA E ABBADESSA A BRUZZESE L LEONI F CIOLLI S CANTONETTI M PAPA G LANDOLFI R LEONE G GALLO E PILERI A ZAGONEL V PINTO A VOLPE E DIFRANCESCO A QUAGLINO D AVANZINI P GOBBI F PAOLINO F RESEGOTTI L SAGLIO G CAMASCHELLA C MAZZA U PINOTTI G VENCO G CAPUCCI A IZZI T MORANDI S BIANCHINI E SCAPOLI GL MONACO M PIZZUTI M RICCIUTI F CAPALDI A GIOVANNELLI E
Citation: M. Gobbi et al., KARYOTYPIC CONVERSION BY INTERFERON AS PREPARATIVE TREATMENT FOR AUTOLOGOUS BMT IN PH POSITIVE CML, Leukemia & lymphoma, 11, 1993, pp. 277-280
EVALUATING SURVIVAL AFTER ALLOGENEIC BONE-MARROW TRANSPLANT FOR CHRONIC MYELOID-LEUKEMIA IN CHRONIC PHASE - A COMPARISON OF TRANSPLANT VERSUS NO-TRANSPLANT IN A COHORT OF 258 PATIENTS 1ST SEEN IN ITALY BETWEEN1984 AND 1986
Authors: TURA S FANIN R RUSSO D ZUFFA F FIACCHINI M BACCARANI M TESTONI N ZAMAGNI D ZACCARIA A DAMIANI D MICHIELI M ALIMENA G MONTEFUSCO E MANDELLI F MORRA E BERNASCONI C GUGLIELMI P CACCIOLA E BATTISTA R DINI E SPECCHIA G LISO V MAJOLINO I CARONIA F LEONI P DANIELI G NOSARI A DECATALDO F PAOLINO F RESEGOTTI L COMOTTI B BARBUI T SCAPOLI GL CASTOLDI GL PROSSOMARITI L MONTUORI R RICCARDI A ASCARI E LANDOLFI R BIZZI B LOMBARDO M TORLONTANO G LEONI F FERRINI PR SPARAVENTI G DELFINI C PAPINESCHI F SPREMOLLA G BROCCIA G NARDELLI S CICCONE F DERIU L MIRAGLIA E DEBIASE R BODENIZZA CA CAROTENUTO M ROTONDO SG GENTILINI I COSER P CAPUCCI A IZZI T LUCIANO L ROTOLI B IACOPINO P NOBILE F CANTONETTI M PAPA G PINOTTI G SALA G FOA P MAIOLO MT AVANZINI P GOBBI F DORE F PARDINI S AMBROSETTI A PERONA G DINI D LIBERATI AM MARTELLI M GRIGNANI F MONTUORO A DELAURENZI A GALLO E PILERI A GALLAMINI A BUFFA F ABBADESSA A BRUZZESE L DEROSA C CIMINO R MANGONI L RIZZOLI V PIZZUTI M RICCIUTI F GALIENI P DISPENSA E ZAGONEL V PINTO A MUSOLINO C SQUADRITO G PERRICONE R CAJOZZO A MORANDI S BIANCHINI E MILIANI A MONACO M DIFRANCESCO A QUAGLINO D ROSTI G MARANGOLO M PASINI FL DIPERRI T AGLIETTA M GAVOSTO F
Citation: S. Tura et al., EVALUATING SURVIVAL AFTER ALLOGENEIC BONE-MARROW TRANSPLANT FOR CHRONIC MYELOID-LEUKEMIA IN CHRONIC PHASE - A COMPARISON OF TRANSPLANT VERSUS NO-TRANSPLANT IN A COHORT OF 258 PATIENTS 1ST SEEN IN ITALY BETWEEN1984 AND 1986, British Journal of Haematology, 85(2), 1993, pp. 292-299
Risultati: 1-18 |